Intellia Therapeutics News

Stifel Nicolaus Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)

TipRanksJul 11 09:25 ET

Intellia Therapeutics Analyst Ratings

BenzingaJun 27 09:38 ET

Canaccord Genuity Maintains Buy on Intellia Therapeutics, Maintains $73 Price Target

BenzingaJun 27 09:38 ET

Intellia Therapeutics Analyst Ratings

BenzingaJun 24 13:36 ET

Intellia Therapeutics Analyst Ratings

BenzingaJun 18 10:12 ET

Intellia Therapeutics Analyst Ratings

BenzingaJun 4 13:30 ET

JMP Securities Remains a Hold on Intellia Therapeutics (NTLA)

TipRanksJun 2 17:16 ET

Oppenheimer Keeps Their Buy Rating on Intellia Therapeutics (NTLA)

TipRanksMay 23 07:55 ET

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Liquidia Technologies (LQDA) and Pacific Biosciences (PACB)

TipRanksMay 14 13:15 ET

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Iovance Biotherapeutics (IOVA) and Intellia Therapeutics (NTLA)

TipRanksMay 14 05:26 ET

Intellia Therapeutics Analyst Ratings

BenzingaMay 10 17:34 ET

Intellia Therapeutics Analyst Ratings

BenzingaMay 10 11:08 ET

Intellia Therapeutics: A Promising Buy Rating Supported by Trial Success and Strong Financials

TipRanksMay 10 08:25 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Catalyst Pharma (CPRX), Xenon (XENE) and Intellia Therapeutics (NTLA)

TipRanksMay 10 07:15 ET

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)

TipRanksMay 10 05:15 ET

JMP Securities Remains a Hold on Intellia Therapeutics (NTLA)

TipRanksMay 10 01:01 ET

Intellia Therapeutics Analyst Ratings

BenzingaApr 23 13:12 ET

Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Legend Biotech (LEGN) and Intellia Therapeutics (NTLA)

TipRanksApr 8 21:51 ET

Intellia Therapeutics (NTLA) Gets a Buy From Truist Financial

TipRanksFeb 27 07:48 ET

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE)

TipRanksFeb 26 08:10 ET